Principal component analysis of the integrated TST signature genes, as well as enrichment of T cell-associated and IFNγ-dependent gene expression modules, indicated that the major features of transcriptional responses in the TST of RA patients were not affected by anti-TNF therapy (Figure 7). The gene discussed is IFNG; the disease is rheumatoid arthritis.